USCB(USCB)
USCB
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $109M | $118M |
| Low | $108M | $117M |
| High | $109M | $120M |
| EBITDA Avg | $32M | $35M |
| Low | $32M | $35M |
| High | $33M | $36M |
| EBIT Avg | $32M | $34M |
| Low | $31M | $34M |
| High | $32M | $35M |
| Net Income Avg | $37M | $41M |
| Low | $36M | $40M |
| High | $37M | $41M |
| EPS Avg | $2.00 | $2.20 |
| Low | $1.98 | $2.16 |
| High | $2.02 | $2.26 |
| Analysts (Rev / EPS) | 3 / 4 | 3 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $28M | $28M | $28M | $29M | $30M | $31M |
| Low | $27M | $28M | $28M | $29M | $30M | $30M |
| High | $28M | $28M | $29M | $30M | $30M | $31M |
| EBITDA Avg | $8M | $8M | $8M | $9M | $9M | $9M |
| Low | $8M | $8M | $8M | $9M | $9M | $9M |
| High | $8M | $8M | $9M | $9M | $9M | $9M |
| EBIT Avg | $8M | $8M | $8M | $8M | $9M | $9M |
| Low | $8M | $8M | $8M | $8M | $9M | $9M |
| High | $8M | $8M | $8M | $9M | $9M | $9M |
| Net Income Avg | $9M | $10M | $9M | $10M | $11M | $11M |
| Low | $9M | $10M | $9M | $10M | $10M | $10M |
| High | $10M | $10M | $10M | $10M | $11M | $11M |
| EPS Avg | $0.51 | $0.52 | $0.51 | $0.54 | $0.57 | $0.57 |
| Low | $0.50 | $0.52 | $0.51 | $0.53 | $0.56 | $0.57 |
| High | $0.53 | $0.53 | $0.52 | $0.55 | $0.58 | $0.58 |
| Analysts (Rev / EPS) | 3 / 4 | 2 / 2 | 1 / 2 | 2 / 1 | 2 / 1 | 1 / 2 |